Pediatric prolactinoma: initial presentation, treatment, and long-term prognosis
- 22 November 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 177 (1) , 125-132
Abstract
Prolactinoma is a rare pituitary adenoma secreting prolactin. Studies on diagnostics, treatment, and prognosis in pediatric prolactinoma patients are rare. We analyzed clinical presentation, response to treatment, and prognosis of 27 pediatric prolactinoma patients (10 m/17 f. based on patients’ records. Tumors included 6 microadenomas (tumor volume: median 0.2 cm3, range 0.01–0.4 cm3; serum prolactin at diagnosis: median 101 ng/ml, range 33–177 ng/ml), 15 macroadenomas (volume: median 3.3 cm3, range 0.4–25.8 cm3; prolactin: median 890 ng/ml, range 87–8624), and 3 giant adenomas (volume: median 44.5 cm3, range 38.6–93.5 cm3; prolactin: median 4720 ng/ml, range 317–10,400); data for 3 patients were not available. Dopamine agonist treatment (n = 22) was safe and effective, leading to reductions in tumor size (p < 0.01) and prolactin levels (p < 0.01). Threat to vision was the indication for decompressing surgery in three of seven operated patients. No patient was irradiated. Long-term functional capacity was not impaired when compared with other sellar masses (n = 235).Keywords
Funding Information
- Deutsche Kinderkrebsstiftung (DKS 2014.13)
This publication has 31 references indexed in Scilit:
- Treatment of hyperprolactinemia: a systematic review and meta-analysisSystematic Reviews, 2012
- Childhood craniopharyngiomaPituitary, 2012
- Clinical Course of Hyperprolactinemia in Children and Adolescents: A Review of 21 Cases - Original ArticleJournal of Clinical Research in Pediatric Endocrinology, 2011
- Prolactinoma in Children and AdolescentsHormone Research in Paediatrics, 2009
- Recurrence of Hyperprolactinemia after Withdrawal of Long-Term Cabergoline TherapyThe Journal of Clinical Endocrinology & Metabolism, 2009
- Valvular heart disease and the use of cabergoline for the treatment of prolactinomaClinical Endocrinology, 2008
- Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart diseaseEuropean Journal of Endocrinology, 2008
- Obesity after childhood craniopharyngioma - German multicenter study on pre-operative risk factors and quality of lifeKlinische Padiatrie, 2001
- Fertigkeitenskala Münster Heidelberg - Ein Meßinstrument zum globalen Vergleich von KrankheitsfolgenKlinische Padiatrie, 1996
- ALTERED PULSATILE SECRETION OF LUTEINIZING HORMONE IN HYPOGONADAL MEN WITH HYPERPROLACTINAEMIAClinical Endocrinology, 1984